- $1.85bn
- $5.24bn
- $5.78bn
- 49
- 89
- 20
- 52
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 5.93 | ||
PEG Ratio (f) | 0.18 | ||
EPS Growth (f) | 49.79% | ||
Dividend Yield (f) | 8.24% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.06 | ||
Price to Tang. Book | 3.33 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.32 | ||
EV to EBITDA | 8.06 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 5.95% | ||
Return on Equity | 12.83% | ||
Operating Margin | 5.88% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 4,969 | 6,345 | 6,794 | 6,027 | 5,782 | 5,874.09 | 6,106.29 | 0.91% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +172.85 | +138.67 | +4.81 | -58.04 | -40 | +54.98 | +42.6 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
The Chemours Company provides industrial and specialty chemical products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. The Company’s segments include Titanium Technologies, Thermal & Specialized Solutions and Advanced Performance Materials. The Titanium Technologies segment is a provider of titanium dioxide pigment, a premium white pigment used to deliver whiteness, brightness, opacity and protection in various applications. The Thermal & Specialized Solutions segment is a provider of refrigerants, thermal management solutions, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment is a provider of high-end polymers and advanced materials. Its flagship products include brands such as Opteon, Freon, Ti-Pure, Nafion, Teflon, Viton, and Krytox. The Company serves over 2,700 customers in approximately 110 countries.
Directors
- Dawn Farrell CHM (61)
- Mark Newman PRE (58)
- Sameer Ralhan CFO (47)
- Alisha Bellezza CEX (45)
- Denise Dignam CEX (55)
- Edwin Sparks CEX (47)
- David Shelton SVP (57)
- Susan Kelliher SVP (54)
- Alvenia Scarborough SVP (47)
- Camela Wisel CAO
- Matthew Abbott VPR (45)
- Sheryl Telford OTH
- Curtis Anastasio IND (64)
- Bradley Bell IND (68)
- Mary Cranston IND (73)
- Curtis Crawford IND (73)
- Erin Kane IND (44)
- Sean Keohane IND (53)
- Guillaume Pepy IND (63)
- Sandra Rogers IND (55)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 18th, 2014
- Public Since
- June 19th, 2015
- No. of Shareholders
- 34,180
- No. of Employees
- 6,000
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
New York Stock Exchange
- Shares in Issue
- 149,440,788

- Address
- 1007 Market Street, WILMINGTON, 19801
- Web
- https://www.chemours.com/
- Phone
- +1 3027731000
- Contact
- Brandon Ontjes
- Auditors
- PricewaterhouseCoopers LLP
Latest News for CC
Upcoming Events for CC
Q1 2025 Chemours Co Earnings Release
Q1 2025 Chemours Co Earnings Call
Chemours Co Annual Shareholders Meeting
Q2 2025 Chemours Co Earnings Release
Similar to CC
AdvanSix
New York Stock Exchange
Air Products and Chemicals
New York Stock Exchange
Albemarle
New York Stock Exchange
Albemarle
New York Stock Exchange
American Vanguard
New York Stock Exchange
FAQ
As of Today at 19:53 UTC, shares in Chemours Co are trading at $12.37. This share price information is delayed by 15 minutes.
Shares in Chemours Co last closed at $12.37 and the price had moved by -54.24% over the past 365 days. In terms of relative price strength the Chemours Co share price has underperformed the S&P500 Index by -57.76% over the past year.
The overall consensus recommendation for Chemours Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Chemours Co dividend yield is 8.08% based on the trailing twelve month period.
Last year, Chemours Co paid a total dividend of $1.00, and it currently has a trailing dividend yield of 8.08%. We do not have any data on when Chemours Co is to next pay dividends.
We do not have data on when Chemours Co is to next pay dividends. The historic dividend yield on Chemours Co shares is currently 8.08%.
To buy shares in Chemours Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $12.37, shares in Chemours Co had a market capitalisation of $1.85bn.
Here are the trading details for Chemours Co:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CC
Based on an overall assessment of its quality, value and momentum Chemours Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Chemours Co is $20.70. That is 67.34% above the last closing price of $12.37.
Analysts covering Chemours Co currently have a consensus Earnings Per Share (EPS) forecast of $1.84 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chemours Co. Over the past six months, its share price has underperformed the S&P500 Index by -28.83%.
As of the last closing price of $12.37, shares in Chemours Co were trading -31.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Chemours Co PE ratio based on its reported earnings over the past 12 months is 5.93. The shares last closed at $12.37.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Chemours Co's management team is headed by:
- Dawn Farrell - CHM
- Mark Newman - PRE
- Sameer Ralhan - CFO
- Alisha Bellezza - CEX
- Denise Dignam - CEX
- Edwin Sparks - CEX
- David Shelton - SVP
- Susan Kelliher - SVP
- Alvenia Scarborough - SVP
- Camela Wisel - CAO
- Matthew Abbott - VPR
- Sheryl Telford - OTH
- Curtis Anastasio - IND
- Bradley Bell - IND
- Mary Cranston - IND
- Curtis Crawford - IND
- Erin Kane - IND
- Sean Keohane - IND
- Guillaume Pepy - IND
- Sandra Rogers - IND